ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 642009 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 642009; 2) Community: the network communities that were significantly associated with the response to NSC 642009; 3) Molecule: the relationships between components within communities and NSC 642009; 4) MDR: the compounds that were significantly associated with the NSC 642009.

NSC Compound Enrichment Correlation
NSC 666787 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate 0.024797903481211 0.42199385
NSC 682352 Null 0.024797903481211 0.075164574
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.024797903481211 0.30484487
NSC 693857 Null 0.024797903481211 0.28568098
NSC 747180 Null 0.024797903481211 -0.075362199
NSC 750104 5,10-dimethoxybenzo[g]quinolin-2(1H)-one 0.024797903481211 0.55356132
NSC 107124 Camptothecin Derivative 0.0267520285931239 0.2690585
NSC 1390 Allopurinol 0.0267520285931239 -0.17016078
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0267520285931239 0.11556803
NSC 302991 Camptothecin Derivative 0.0267520285931239 0.20932379
Total:72  Current:39    [First] [Prev] [Next] [Last]